- Previous Close
0.2870 - Open
0.2900 - Bid 0.2840 x --
- Ask 0.2900 x --
- Day's Range
0.2810 - 0.2900 - 52 Week Range
0.2700 - 0.6640 - Volume
16,092 - Avg. Volume
38,177 - Market Cap (intraday)
7.469M - Beta (5Y Monthly) -0.51
- PE Ratio (TTM)
-- - EPS (TTM)
-0.1500 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
0.40
BBS-Bioactive Bone Substitutes Oyj, a biomedical technology company, develops, manufactures, and commercializes bioactive medical devices and implants for orthopedic surgery in Finland. It offers ARTEBONE, an orthobiological product based on tricalcium phosphate and natural spectrum of bone proteins used primarily for the treatment of bone defects and healing problems in extremities, such as foot and ankle. The company was incorporated in 1991 and is headquartered in Oulu, Finland.
www.bbs-artebone.fiRecent News: BONEH.HE
View MorePerformance Overview: BONEH.HE
Trailing total returns as of 10/25/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: BONEH.HE
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: BONEH.HE
View MoreValuation Measures
Market Cap
7.47M
Enterprise Value
12.20M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
1.97
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-3.56M
Diluted EPS (ttm)
-0.1500
Balance Sheet and Cash Flow
Total Cash (mrq)
850k
Total Debt/Equity (mrq)
147.11%
Levered Free Cash Flow (ttm)
--